Pharmaceutical

Roche announced the launch of the Roche Genentech Innovation Center in March of 2025 on Harvard’s Enterprise Research Campus in Allston. With an initial lease of 30,000 sf of lab space in the first phase of construction, Roche intends to expand their R&D presence to eventually accommodate 500 employees. The initiative will bring together cardiovascular, renal, and metabolism experts with data science and AI specialists to accelerate innovation in drug discovery and development.

The 2024 SEFA Lab of the Year was awarded to the new Roche Pharma Research and Early Development (pRED) Center in Basel, Switzerland, that opened in September 2024 as a state-of-the-art research center dedicated to the discovery and development of groundbreaking drugs. The pRED Center exemplifies the future of transformative research by fostering innovation and collaboration, and embodying Roche’s commitment to advancing global healthcare and delivering life-changing treatments. 

An evolution of the equipment and technology researchers need is transforming ordinary labs into facilities that deserve to be called next-generation or future-ready. Significant changes in space utilization and lab planning and design are driven by increased automation and robotics, the incorporation of manufacturing, enhanced information technology with an emphasis on data collection, ever-evolving technologies, developer core/shell fit-outs, hybrid work patterns, and different approaches to project delivery and construction. 

Moderna completed construction on a £150 million complex in the United Kingdom for the discovery and production of mRNA vaccines and therapeutics for COVID-19 and emerging respiratory health threats. Located on the Harwell Campus in Oxfordshire, the Moderna Innovation and Technology Centre (MITC) comprises two 145,000-sf buildings for research, development, and manufacturing.

BioMed Realty is constructing a 637,000-sf life sciences facility in Cambridge for Takeda Pharmaceuticals. Designed by CBT Architects, the 16-story structure will provide advanced lab and office environments to accelerate the creation of innovative therapies and vaccines. Featuring flexible spaces to optimize in-person interaction and connection in a hybrid working model, the leased building furthers Takeda’s goal of unifying their Global R&D Center in Kendall Square.

The past few decades have brought myriad technological changes to our daily lives, and experts predict the pace of change will only increase—especially in the use of artificial intelligence (AI) tools. Much of the talk surrounding AI focuses on automating repetitive processes and analyzing data, which require additional computational power but not necessarily structural modifications. But emerging technologies, including AI and robotics, may require universities and companies to rethink their approach to designing and planning buildings and labs.

The fast-moving nature of biotechnology innovation means architects and designers for Regeneron have to plan for researchers’ requirements to change by the time new laboratories open on the Tarrytown, N.Y., campus. The campus is undergoing a $1.8 billion expansion, adding 900,000 sf of new laboratory and office space, along with additional parking, amenities, and infrastructure to support research and development.

Kadans Science Partner is constructing a 139,000-sf facility in Cambridge in the United Kingdom that will catalyze the discovery of new therapies, medical devices, and digital healthcare solutions. Providing fully fitted, best-in-class research environments, Merlin Place will offer CL2 wet labs, dry labs, and dedicated office spaces. A flexible structural grid with adaptable floor heights will support a range of configurations in the building, which will utilize a modular layout to accommodate multiple tenants or a single entity.

Breakthrough Properties celebrated the opening of a 510,000-sf life sciences campus in San Diego in October of 2024. Designed by Flad Architects, Torrey View by Breakthrough offers state-of-the-art wet labs for the development of novel therapies and technologies, as well as flexible workspaces and collaboration areas. An iconic tessellated envelope allows interior floor plates to be infused with natural light, maximizing occupant wellness and energy efficiency without compromising performance.

Takeda Pharmaceuticals and Boston Medical Center (BMC) have initiated a strategic research collaboration to decarbonize the value chain throughout the healthcare ecosystem. One of the most difficult environmental challenges facing the industry today is greenhouse gas (GHG) emissions released from the disposal of regulated medical waste, including pharmaceutical packaging and single-use plastics. A key objective of this analysis is to effectively identify, pilot, and share decarbonization solutions that other healthcare organizations can adopt.

MilliporeSigma, a subsidiary of Merck KGaA, opened a $317.2 million facility in Rockville in October of 2024. Located in the Alexandria Center at Traville Gateway, the 260,000-sf building provides advanced laboratories for biosafety testing, analytical development, viral clearance, and cell bank manufacturing. The project represents the company's largest investment to date in contract testing operations.

King Street Properties has announced the substantial completion of the South Building at the Landing, a purpose-built complex for biomedical innovation. Designed by Perkins&Will, the seven-story, 300,000-sf facility offers 46,500-sf floor plates and advanced MEP systems to support a 60/40 lab-to-office ratio. Robust research programs can be accommodated by 15-foot deck-to-deck heights, with expansive 20-foot heights available on the ground floor.

Breakthrough Properties is constructing a 225,000-sf life sciences facility in Philadelphia. Designed by KieranTimberlake, the nine-story building will offer best-in-class research environments for biomedical and pharmaceutical tenants. The purpose-built structure will feature open floorplates with highly flexible lab zones that can accommodate a wide range of programs.

The University of Nebraska Medical Center is constructing the $105 million Campus Operations and Research Excellence (CORE) building in Omaha. Designed by LEO A DALY, the six-level, 180,870-gsf structure will feature three stories of state-of-the-art wet labs, including a 30,800-sf floor for research programs in oncology, drug discovery, and other strategic priorities. Approximately 61,600 sf of leasable shell space will accommodate private tenants or supply additional capacity for future growth.

Scripps Research Institute opened the Chi-Huey Wong Laboratories for Biomedical Research in August of 2024. Creating a new gateway to the La Jolla campus, the 83,000-sf structure provides leading-edge environments for drug discovery and development. DGA was the architect for the collaborative facility, which features interconnected open laboratories and a double-height lobby.